Table 5 Results of meta-analysis in different statins groups
  Group | Included arms (and case) | Pooled SMD (95% CI, p) | Heterogeneity test | Sensitivity analyses | Egger’s test | ||
|---|---|---|---|---|---|---|---|
χ2test ( p) | I 2 | Lower SMD (95% CI) | Upper SMD (95% CI) | ||||
Rosuvastatin | 5 (1173) | -0.162 (-0.234~ -0.081, 0.000) | 0.37 (0.985) | 0 | -0.153 (-0.249~-0.056) | -0.178 (-0.287~-0.069) | 0.770 |
Without 2006 ASTEROID Ros | Without 2011 SATURN Ros | ||||||
Atorvastatin | 8 (1138) | -0.101 (-0.184~ -0.019, 0.016) | 4.44 (0.728) | 0 | -0.075 (-0.162~0.012) | -0.132 (-0.225~-0.038) | 0.582 |
Without 2009 JAPAN-ACS Ato | Without 2004 REVERSAL Ato | ||||||
Pitavastatin | 1 (125) | -0.304 (-0.553~-0.055, 0.017) | Â | Â | Â | Â | Â |
Fluvastatin | 1 (40) | -0.169 (-0.608~0.270, 0.450) | Â | Â | Â | Â | Â |
Simvastatin | 2 (90) | -0.10 (-0.393~ 0.192, 0.501) | 0.04 (0.846) | 0 | -0.074 (-0.467~0.318) | -0.133 (-0.572~0.360) | 0.000 |
Without 2004 Jensen LO Sim | Without 2009 Hong MK Sim | ||||||
Pravastatin | 3 (319) | -0.008 (-0.163~0.147, 0.920) | 1.86 (0.395) | 0 | -0.005 (-0.165~0.154) | 0.039 (-0.131~0.208) | 0.528 |
Without 2005 Kawasaki M Pra | Without 2005 Tani S Pra | ||||||